Dexcom held its 2026 Investor Day on May 14, with President and Chief Executive Officer Jake Leach highlighting priorities for the company's next phase of expansion.
The event, which began at 4:15 p.m. EDT, featured Leach welcoming attendees and emphasizing Dexcom's focus on improving diabetes management while reducing overall care costs. He identified three main drivers for future growth, starting with an advanced product portfolio designed to address key customer needs.
Acadia Pharmaceuticals Inc. released a slide deck for its first-quarter 2026 earnings call on May 6.
Rapportert av AI
Gen Digital Inc. conducted its fourth quarter fiscal 2026 earnings call on May 7. The event featured remarks from company executives and addressed financial performance.
Illumina Inc. conducted its first-quarter 2026 earnings conference call on April 30, 2026, at 4:30 PM EDT. CEO Jacob Thaysen and CFO Ankur Dhingra presented updates on the business and financial results. The company released its earnings after market close, available on its investor relations website.
Rapportert av AI
Aytu BioPharma conducted its earnings call for the fiscal 2026 third quarter on May 13, 2026. Executives discussed operational and financial results for the period ended March 31, 2026.